Reduced tears (ST ⩽5 mm) | Reduced saliva (UWS ⩽5 ml) | ||||||
---|---|---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | ||||
Age (y) | |||||||
⩽40 | 1.0 | 1.0 | |||||
41–50 | 0.88 | 0.47, 1.65 | 0.99 | 0.40, 2.44 | |||
51–60 | 0.88 | 0.49, 1.57 | 1.19 | 0.52, 2.71 | |||
61–70 | 0.86 | 0.48, 1.53 | 1.82 | 0.83, 3.96 | |||
Sex | |||||||
Male | 1.0 | 1.0 | |||||
Female | 1.18 | 0.74, 1.87 | 1.35 | 0.39, 2.41 | |||
Drug with dryness potential | 0.78 | 0.48, 1.30 | 1.35 | 0.79, 2.30 | |||
Rheumatoid factor | 1.53* | 1.04, 2.24 | 0.90 | 0.55, 1.47 | |||
Number of sicca symptoms | |||||||
0 | 1.0 | 1.0 | |||||
1 | 0.98 | 0.54, 1.66 | 1.08 | 0.49, 2.39 | |||
2–3 | 1.78* | 1.11, 2.85 | 3.11** | 1.66, 5.81 | |||
4–6 | 2.25* | 1.18, 4.28 | 5.59*** | 2.63, 11.89 | |||
Disease activity score | |||||||
Lowest quartile | 1.0 | 1.0 | |||||
2.quartile | 0.61 | 0.35, 1.08 | 1.08 | 0.48, 2.46 | |||
3.quartile | 0.88 | 0.51, 1.54 | 1.61 | 0.74, 3.48 | |||
Highest quartile | 1.08 | 0.62, 1.89 | 2.45* | 1.15, 5.24 |
↵3-151 OR adjusted for age, sex, disease duration, drugs with capacity to induce sicca symptoms, rheumatoid factor, number of sicca symptoms, and disease activity score. *p<0.05, **p<0.001,***p<0.0001.